Estrem ST - Search Results

1

Data-driven analysis approach for biomarker discovery using molecular-profiling technologies.

Wei T, Liao B, Ackermann BL, Jolly RA, Eckstein JA, Kulkarni NH, Helvering LM, Goldstein KM, Shou J, Estrem ST, Ryan TP, Colet JM, Thomas CE, Stevens JL, Onyia JE. Wei T, et al. Among authors: estrem st. Biomarkers. 2005 Mar-Jun;10(2-3):153-72. doi: 10.1080/13547500500107430. Biomarkers. 2005. PMID: 16076730

2

Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants.

Jolly RA, Goldstein KM, Wei T, Gao H, Chen P, Huang S, Colet JM, Ryan TP, Thomas CE, Estrem ST. Jolly RA, et al. Among authors: estrem st. Physiol Genomics. 2005 Aug 11;22(3):346-55. doi: 10.1152/physiolgenomics.00260.2004. Epub 2005 May 24. Physiol Genomics. 2005. PMID: 15914576

3

Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.

Helvering LM, Adrian MD, Geiser AG, Estrem ST, Wei T, Huang S, Chen P, Dow ER, Calley JN, Dodge JA, Grese TA, Jones SA, Halladay DL, Miles RR, Onyia JE, Ma YL, Sato M, Bryant HU. Helvering LM, et al. Among authors: estrem st. Biol Reprod. 2005 Apr;72(4):830-41. doi: 10.1095/biolreprod.104.034595. Epub 2004 Dec 1. Biol Reprod. 2005. PMID: 15576828

4

Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults.

Raue U, Trappe TA, Estrem ST, Qian HR, Helvering LM, Smith RC, Trappe S. Raue U, et al. Among authors: estrem st. J Appl Physiol (1985). 2012 May;112(10):1625-36. doi: 10.1152/japplphysiol.00435.2011. Epub 2012 Feb 2. J Appl Physiol (1985). 2012. PMID: 22302958 Free PMC article.

5

Assessment of diet-induced obese rats as an obesity model by comparative functional genomics.

Li S, Zhang HY, Hu CC, Lawrence F, Gallagher KE, Surapaneni A, Estrem ST, Calley JN, Varga G, Dow ER, Chen Y. Li S, et al. Among authors: estrem st. Obesity (Silver Spring). 2008 Apr;16(4):811-8. doi: 10.1038/oby.2007.116. Epub 2008 Jan 24. Obesity (Silver Spring). 2008. PMID: 18239588 Free article.

6

Old and new approaches used to identify gene products important for Saccharomyces cerevisiae cell wall biology.

Estrem ST, Skatrud PL. Estrem ST, et al. J Ind Microbiol Biotechnol. 2001 Dec;27(6):357-9. doi: 10.1038/sj.jim.7000205. J Ind Microbiol Biotechnol. 2001. PMID: 11774000 Review. No abstract available.

7

Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.

Yadav V, Zhang X, Liu J, Estrem S, Li S, Gong XQ, Buchanan S, Henry JR, Starling JJ, Peng SB. Yadav V, et al. J Biol Chem. 2012 Aug 10;287(33):28087-98. doi: 10.1074/jbc.M112.377218. Epub 2012 Jun 22. J Biol Chem. 2012. PMID: 22730329 Free PMC article.

8

Genome of the bacterium Streptococcus pneumoniae strain R6.

Hoskins J, Alborn WE Jr, Arnold J, Blaszczak LC, Burgett S, DeHoff BS, Estrem ST, Fritz L, Fu DJ, Fuller W, Geringer C, Gilmour R, Glass JS, Khoja H, Kraft AR, Lagace RE, LeBlanc DJ, Lee LN, Lefkowitz EJ, Lu J, Matsushima P, McAhren SM, McHenney M, McLeaster K, Mundy CW, Nicas TI, Norris FH, O'Gara M, Peery RB, Robertson GT, Rockey P, Sun PM, Winkler ME, Yang Y, Young-Bellido M, Zhao G, Zook CA, Baltz RH, Jaskunas SR, Rosteck PR Jr, Skatrud PL, Glass JI. Hoskins J, et al. Among authors: estrem st. J Bacteriol. 2001 Oct;183(19):5709-17. doi: 10.1128/JB.183.19.5709-5717.2001. J Bacteriol. 2001. PMID: 11544234 Free PMC article.

9

First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma.

Rodon J, Carducci MA, Sepulveda-Sánchez JM, Azaro A, Calvo E, Seoane J, Braña I, Sicart E, Gueorguieva I, Cleverly AL, Pillay NS, Desaiah D, Estrem ST, Paz-Ares L, Holdhoff M, Blakeley J, Lahn MM, Baselga J. Rodon J, et al. Among authors: estrem st. Clin Cancer Res. 2015 Feb 1;21(3):553-60. doi: 10.1158/1078-0432.CCR-14-1380. Epub 2014 Nov 25. Clin Cancer Res. 2015. PMID: 25424852 Free PMC article. Clinical Trial.

10

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM. Herbertz S, et al. Among authors: estrem st. Drug Des Devel Ther. 2015 Aug 10;9:4479-99. doi: 10.2147/DDDT.S86621. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26309397 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters